These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9594232)

  • 21. [Clinical experiences with UFD-1].
    Furue H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):672-4. PubMed ID: 6820905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
    Iwasaki K; Oida I; Usami A; Hashimoto Y; Yamada M; Ozawa T
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):369-72. PubMed ID: 10065103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UFT and S-1 for treatment of primary lung cancer.
    Tanaka F; Wada H; Fukushima M
    Gen Thorac Cardiovasc Surg; 2010 Jan; 58(1):3-13. PubMed ID: 20058135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients.
    Etienne-Grimaldi MC; Cardot JM; François E; Renée N; Douillard JY; Gamelin E; Milano G
    Clin Pharmacol Ther; 2008 Mar; 83(3):413-5. PubMed ID: 17637782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III randomized comparison of postoperative adjuvant chemotherapy with 2-year oral UFT (uracil/tegafur) versus six-cycle CMF (cyclophosphamide/methotrexate/5-fluorouracil) in high-risk node-negative breast cancer patients.
    Watanabe T
    Jpn J Clin Oncol; 1998 Jan; 28(1):77-80. PubMed ID: 9491146
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant chemotherapy for adenocarcinoma of the lung--is the standard of care ready for change?
    Diasio RB
    N Engl J Med; 2004 Apr; 350(17):1777-9. PubMed ID: 15103005
    [No Abstract]   [Full Text] [Related]  

  • 27. [A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
    Kimura M; Inoue M; Morisaki T; Kaneda H; Kume S; Matsushita H; Horino K; Nishimura T; Arima T; Uemura K
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):529-31. PubMed ID: 15853222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of tegafur/uracil in pulmonary malignancy.
    Langer CJ
    Drugs; 1999; 58 Suppl 3():71-5. PubMed ID: 10711844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
    Colevas AD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of S-1].
    Hirata K; Horikoshi N; Tominaga K; Sohma K; Yamaguchi K; Okazaki M; Furuhata T; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Yamamitsu S; Shirasaka T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():27-35. PubMed ID: 16897969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
    Hiraga T; Ueda A; Tamura D; Hata K; Ikeda F; Williams PJ; Yoneda T
    Int J Cancer; 2003 Oct; 106(6):973-9. PubMed ID: 12918079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of carcinoma of lower lip showing excellent response to chemotherapy with UFT].
    Kasai N; Mutoh Y
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):373-6. PubMed ID: 10065104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
    Goto R; Yoshikawa H; Ota M; Ikeuchi T; Kai Y
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2287-91. PubMed ID: 9881087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [UFT].
    TakuchiT
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1692-6. PubMed ID: 6433802
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
    Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
    Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma.
    Akay S; Ozütemiz O; Doganavsargil B
    Expert Opin Drug Saf; 2004 Mar; 3(2):89-92. PubMed ID: 15006714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
    Haseme E; Shohkei O; Ohnishi Y; Kikuchi K
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):247-51. PubMed ID: 11242656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The serum and tissue concentration of FT-207, 5'-DFUR and 5-FU in patients with breast cancer by preoperative administration of UFT and 5'-DFUR].
    Kosaka A; Sumiyoshi K; Ando J
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):277-80. PubMed ID: 2521996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.